TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 3 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $858,759 | -14.3% | 55,511 | -13.0% | 0.03% | -16.1% |
| Q2 2023 | $1,001,862 | +1.3% | 63,772 | +6.4% | 0.03% | -8.8% |
| Q1 2023 | $988,894 | +81.3% | 59,928 | +71.4% | 0.03% | +47.8% |
| Q4 2022 | $545,423 | -19.4% | 34,963 | -33.0% | 0.02% | -25.8% |
| Q3 2022 | $677,000 | +14.4% | 52,192 | +23.7% | 0.03% | +14.8% |
| Q2 2022 | $592,000 | +26.0% | 42,186 | +28.6% | 0.03% | +17.4% |
| Q1 2022 | $470,000 | +107.0% | 32,813 | +97.2% | 0.02% | +76.9% |
| Q4 2021 | $227,000 | -16.5% | 16,643 | +0.1% | 0.01% | -45.8% |
| Q3 2021 | $272,000 | +7.9% | 16,630 | +11.2% | 0.02% | -7.7% |
| Q2 2021 | $252,000 | -21.0% | 14,958 | -14.3% | 0.03% | -45.8% |
| Q1 2021 | $319,000 | -10.1% | 17,446 | -10.7% | 0.05% | -37.7% |
| Q4 2020 | $355,000 | -4.3% | 19,528 | -6.1% | 0.08% | -26.0% |
| Q3 2020 | $371,000 | +18.5% | 20,796 | +19.0% | 0.10% | -26.8% |
| Q2 2020 | $313,000 | – | 17,473 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |